Most women understand that menopause involves hot flashes, sleep disruption, and changes in their cycles. What most women are never told is that the hormonal shift of menopause changes the terrain of the entire body in ways that go far beyond those familiar symptoms — and that this shift creates a window of significantly increased susceptibility to chronic conditions that may have been dormant, controlled, or simply not yet relevant.
The story behind this article is about a woman with trigeminal neuralgia — one of the most painful conditions a human being can experience — who had been told by her neurologist that she would have to live with it for the rest of her life. She had tried Botox, multiple medications, and was facing surgery with no guarantee of success. Three years after working together, she has been completely pain-free. You can read her full story here: Her Neurologist Said She Would Have to Live With It. Three Years Later, the Pain Has Never Come Back.
What her case illustrates is something I see in different forms regularly: menopause does not cause new diseases so much as it removes the physiological buffers that were keeping existing vulnerabilities in check. Understanding what those buffers are, how they work, and what happens when they are no longer present is essential for any woman who wants to navigate this transition with her long-term health intact.
Key Highlights
- Estrogen and progesterone are not just reproductive hormones. They are anti-inflammatory, neuroprotective, immune-modulating, and metabolically stabilizing agents that affect virtually every system in the body
- Their decline at menopause shifts the body's inflammatory environment, immune regulation, nervous system resilience, and metabolic stability simultaneously
- Conditions that were dormant, subclinical, or controlled — including latent viral infections, autoimmune tendencies, metabolic dysfunction, and inflammatory pain syndromes — can surface or accelerate when these hormonal buffers are removed
- The menopausal transition is not the cause of these conditions, but it is often the trigger that makes them visible and disabling
- Addressing the hormonal environment alongside the specific condition — rather than treating the condition in isolation — is what makes resolution possible in cases where conventional treatment alone has failed
What Estrogen and Progesterone Actually Do in the Body
To understand why their decline matters so much, it helps to understand what these hormones are doing when they are present.
Estrogen is one of the body's most powerful anti-inflammatory agents. It modulates the activity of inflammatory cytokines, supports the integrity of the gut lining, promotes cerebral blood flow, supports mitochondrial function, and directly suppresses the NF-kB pathway — one of the primary molecular switches for inflammation in the body. It also plays a critical role in immune regulation, influencing the balance between immune tolerance and immune reactivity. When estrogen is present at adequate levels, the body has a significant physiological bias toward controlling inflammation and containing immune overactivation.
Progesterone complements and extends these effects. It has direct anti-inflammatory properties, supports GABA receptor function in the brain which governs anxiety and sleep, modulates immune function in ways that reduce autoimmune reactivity, and — critically — helps potentiate thyroid hormone at the cellular level, supporting how effectively T3 enters and activates cells. When progesterone is adequate, it acts as a downstream stabilizer for multiple systems simultaneously.
Both hormones are also neuroprotective. They support the production and maintenance of myelin, the insulating sheath around nerve fibers that governs how efficiently and accurately nerves conduct signals. They reduce neuroinflammation. They support the brain's ability to suppress latent viral activity and manage the immune responses that, when dysregulated, can keep a nervous system in a state of chronic irritation.
When these hormones decline — first progesterone in the early perimenopausal years, then estrogen as menopause approaches — all of these functions are reduced. The body loses anti-inflammatory capacity. Immune regulation becomes less precise. The nervous system becomes more vulnerable to irritation and less capable of recovery. Metabolic stability decreases. The threshold for conditions that require these buffers to stay controlled drops significantly.
The Inflammatory Environment of Menopause
One of the most significant and least discussed consequences of hormonal decline at menopause is the shift in the body's baseline inflammatory state. This is not inflammation in the acute sense of a wound or an infection. It is a shift in the chronic, low-grade inflammatory tone of the body — a change in the background level of inflammatory signaling that affects everything from joint comfort to cardiovascular risk to neurological resilience.
Research consistently shows that inflammatory markers rise in the menopausal transition. CRP, homocysteine, fibrinogen, and inflammatory cytokines including IL-6 and TNF-alpha all tend to increase as estrogen declines. This is not coincidental. Estrogen was actively suppressing these markers. When it is no longer present at adequate levels, inflammatory signaling increases, and conditions that depend on a controlled inflammatory environment to remain stable can begin to shift.
For women with latent viral infections — including the varicella-zoster virus responsible for shingles — this shift in inflammatory environment can be the difference between a controlled infection and one that reactivates or sustains chronic nerve irritation. For women with autoimmune tendencies that were previously subclinical, the removal of estrogen's immune-modulating effects can tip the balance toward overt autoimmune activity. For women with existing inflammatory conditions, the loss of estrogen's anti-inflammatory influence can accelerate symptom burden significantly.
This is not aging. It is a specific, physiologically explainable consequence of hormonal decline that has a specific, addressable solution.
Latent Viral Infections and Menopause
The connection between menopause and viral reactivation is one of the most underappreciated areas in women's health. The varicella-zoster virus, which causes chickenpox in childhood and shingles in adulthood, is never fully eliminated from the body. It retreats into the dorsal root ganglia — clusters of nerve cell bodies along the spinal cord — and remains latent, held in check by immune surveillance. When immune function is strong and inflammatory control is robust, the virus stays quiet. When immune function is compromised, the virus can reactivate.
Menopause compromises immune function in specific ways. Estrogen's influence on natural killer cell activity, T cell regulation, and the suppression of inflammatory cytokines all contribute to a more permissive environment for latent viral activity. Women going through menopause are more susceptible to shingles outbreaks, and when those outbreaks involve cranial nerves — including the trigeminal nerve — the consequences can include post-herpetic neuralgia that persists long after the acute infection has resolved.
What makes this clinically significant is that the viral component is rarely addressed in the ongoing management of trigeminal neuralgia or other post-herpetic pain syndromes. The nerve is treated. The pain is managed. The virus and the immune environment that allowed it to cause ongoing damage are left completely unaddressed. And so the pain continues, because the underlying driver has never been touched.
Blood Sugar, Candida, and the Body's Ability to Heal
Two additional factors that are frequently present in menopausal women with chronic inflammatory conditions — and frequently overlooked — are blood sugar dysregulation and candida overgrowth.
Blood sugar instability increases in the menopausal transition as insulin sensitivity declines with falling estrogen. Chronically elevated blood sugar creates a pro-inflammatory environment, impairs immune function, and directly affects the nervous system's ability to heal and regulate. Advanced glycation end products formed in the presence of high blood sugar damage nerve fibers and contribute to the kind of neurological vulnerability that makes conditions like trigeminal neuralgia harder to resolve. A nervous system that is operating in a chronically high blood sugar environment does not have the metabolic stability to downregulate pain signaling effectively.
Candida overgrowth is extraordinarily common in menopausal women and is almost never considered in the context of chronic pain or neurological conditions. Candida produces inflammatory byproducts, disrupts gut integrity, contributes to systemic immune dysregulation, and sustains a state of chronic low-grade inflammation that makes resolution of any condition dependent on immune regulation significantly harder. When candida is present and unaddressed, it acts as a persistent inflammatory driver that undermines every other intervention being applied.
In the trigeminal neuralgia patient discussed in the companion piece, both of these factors were present. Neither had been identified or addressed in eight years of conventional treatment. Both were part of the clinical picture that had to be resolved before the nervous system could finally settle.
Cortisol and the Stress Burden
Chronic stress and cortisol dysregulation compound every factor described above. Elevated cortisol suppresses immune function, increases gut permeability, disrupts blood sugar regulation, reduces the body's ability to suppress viral reactivation, and sustains neuroinflammation. In menopausal women, who are already navigating a significant hormonal transition while frequently managing demanding professional and family responsibilities, cortisol burden is rarely low.
A nervous system under chronic cortisol pressure is a nervous system that cannot downregulate its own pain signaling effectively. The fight-or-flight state that elevated cortisol sustains is physiologically incompatible with the parasympathetic conditions under which healing, nerve repair, and viral suppression occur. Addressing the stress and cortisol picture is not a soft intervention. It is a biological requirement for resolution in conditions where the nervous system is the primary site of pathology.
Nutrient Deficiencies That Compound Nervous System Vulnerability at Menopause
The inflammatory, viral, and metabolic factors described above do not operate in a nutritional vacuum. Several nutrient deficiencies that are extremely common in menopausal women directly compound nervous system vulnerability and impair the body's capacity for recovery.
Vitamin B12 is essential for myelin production and maintenance. Deficiency produces neurological symptoms including numbness, tingling, and nerve pain that can be difficult to distinguish from other causes of neuropathy. B12 absorption declines with age, is impaired by certain medications including metformin and proton pump inhibitors that are commonly prescribed to menopausal women, and is further compromised by gut dysfunction. A woman with B12 deficiency and trigeminal nerve irritation from viral activity is dealing with a nerve that is structurally compromised at the same time it is being functionally provoked.
Magnesium plays a critical role in regulating nerve excitability. It acts as a natural calcium channel blocker, moderating the rate at which nerve cells fire. Magnesium deficiency, which is extremely common and almost never tested, leaves nerves in a state of hyperexcitability that makes pain signaling more intense and more persistent. For a woman with trigeminal neuralgia, where the nerve is already in a state of abnormal excitability, magnesium deficiency removes a key physiological brake on the pain response.
Vitamin D's role in immune function and inflammation regulation makes it directly relevant to both viral suppression and inflammatory pain syndromes. Low vitamin D impairs the immune surveillance that keeps latent viruses controlled, reduces the body's anti-inflammatory capacity, and is associated with increased pain sensitivity. Deficiency is nearly universal in women over 45 in the Bay Area, and its contribution to the clinical picture in chronic pain conditions is consistently underestimated.
Omega-3 fatty acids are essential for neuronal membrane integrity and for the resolution of neuroinflammation. The brain and nervous system are composed largely of DHA, the primary long-chain omega-3 found in neural tissue. When omega-3 levels are low, the nervous system's capacity to resolve inflammation, repair damaged tissue, and modulate pain signaling is compromised. Most menopausal women have omega-3 levels well below optimal, and the gap between dietary intake and what the nervous system needs during a period of increased inflammatory challenge is often significant.
What Addressing the Whole Picture Actually Looks Like
The conditions that become visible or worsen at menopause are not random. They are the predictable result of specific physiological shifts — in inflammation, immune function, nervous system resilience, metabolic stability, and viral suppression — that occur when hormonal support is removed. And because those shifts are specific and physiologically explainable, they are addressable.
Addressing them requires looking at the whole picture simultaneously. The hormonal environment. The viral component. The inflammatory load from blood sugar and candida. The cortisol and stress pattern. The nutritional deficiencies that compound every other factor. These are not separate problems requiring separate specialists. They are interconnected aspects of a single clinical picture, and the only way to resolve that picture is to address all of them together.
This is what conventional treatment for conditions like trigeminal neuralgia rarely does. It treats the nerve. It manages the pain. It does not ask why the nerve is behaving the way it is, what the immune and inflammatory environment looks like, what viral burden may be sustaining the irritation, or what metabolic and hormonal factors are preventing resolution. And so the condition continues, because the questions that would lead to resolution are not being asked.
What This Means for Women in Perimenopause and Menopause
The menopausal transition is the most significant hormonal shift in a woman's life outside of pregnancy. It changes the body's operating environment in ways that affect every system. The conditions that surface or worsen during this transition are not inevitable. They are the result of specific changes in specific systems, and those changes can be measured, addressed, and in many cases substantially reversed.
What this means practically is that the perimenopausal and menopausal years are not a time to manage symptoms and wait. They are the time to look carefully at the full picture — inflammatory load, viral burden, blood sugar, hormonal status, immune function, and toxic load — and address what is found before conditions that are currently manageable become conditions that are not.
The woman who spent eight years disabled by trigeminal neuralgia was not beyond help. She was beyond what conventional medicine was willing to look for. Those are very different things.
Some details have been changed to protect patient privacy. The clinical outcomes are real.
If you are in Menlo Park, Palo Alto, Atherton, Los Altos, Woodside, Portola Valley, or Redwood City and you are navigating the menopausal transition with chronic symptoms that have not responded to conventional treatment, schedule a Discovery Call.
Frequently Asked Questions
Can menopause cause nerve pain?
Menopause does not directly cause nerve pain, but the hormonal changes of menopause — particularly the loss of estrogen's and progesterone's neuroprotective and anti-inflammatory effects — can create conditions that allow existing nerve vulnerabilities to worsen or become symptomatic. Women with a history of shingles are particularly susceptible to post-herpetic nerve pain during and after the menopausal transition because the immune changes of menopause can allow previously controlled viral activity to become more disruptive.
Why does chronic pain often worsen at menopause?
Estrogen has direct anti-inflammatory effects and directly modulates pain signaling in the central nervous system. Its decline at menopause removes these moderating influences, and the baseline inflammatory state of the body rises. Conditions that were previously controlled within the inflammatory environment estrogen helped maintain can become more symptomatic as that environment shifts. Blood sugar instability, which also increases at menopause, further compromises the nervous system's ability to regulate pain signals effectively.
What is the connection between shingles and trigeminal neuralgia?
The varicella-zoster virus can affect cranial nerves including the trigeminal nerve during a shingles outbreak. In some cases, the nerve irritation that begins with the acute infection does not resolve and becomes a persistent pain syndrome called post-herpetic neuralgia. When the trigeminal nerve is involved, this manifests as the severe, episodic facial pain characteristic of trigeminal neuralgia. The viral component is often never addressed in ongoing treatment, which is one reason these conditions can persist indefinitely when managed only with pain-suppressing interventions.
What is candida and how does it relate to chronic pain?
Candida is a yeast that normally resides in the gut in controlled amounts. When it overgrows — which is more common in women with blood sugar dysregulation, a history of antibiotic use, or compromised immune function — it produces inflammatory byproducts, disrupts gut integrity, and sustains a state of chronic immune activation and systemic inflammation. In the context of a nervous system that is already vulnerable, candida's inflammatory contribution can be significant and can prevent resolution of conditions that might otherwise respond to treatment.
How long does it take to see results when addressing these underlying factors?
It depends on how long the underlying dysfunction has been present and how many systems are involved. In the case of the patient described in this piece, meaningful and lasting resolution came within approximately two months of addressing the viral component, candida, blood sugar, hormones, and stress picture together. Not every case resolves this quickly, but when the right factors are identified and addressed in the right order, the body responds. The nervous system, in particular, has significant capacity for recovery when the conditions that have been sustaining its dysfunction are removed.
Related reading:
- Why Hormone Replacement Alone Is Not Enough
- Why Stress Hits Women Over 45 Completely Differently
- What a Complete Lab Panel Reveals That 30 Years of Doctor Visits Missed
- Chronic Inflammation Is Probably Behind Your Fatigue, Brain Fog, and Low Energy
For further reading on the relationship between hormones, inflammation, and chronic pain in women, the National Institute of Neurological Disorders and Stroke provides clinical information on trigeminal neuralgia and its mechanisms.